Abstract
Summary: Single doses of 2 mg/kg of furosemide (F) were given postprandially as tablets to 17 steroid-responsive nephrotic syndrome (NS) patients, 2.5–15 years old, and seven control children requiring F therapy. One-half, 1, and 2 h after administration, F absorption rate, calculated from the drug urinary excretion data, was significantly more rapid in the NS patients compared to that in the controls. Bioavailability of F in the nephrotic children averaged 58.8% indicating that the gastrointestinal absorption of the drug was unaffected by the disease and by the age of the patients. The first pass effect of F was 24% of the administered dose. The elimination half-life of F, calculated from the drug urinary excretion data in the NS patients was 2.06 ± 0.96 h (mean ± SD), whereas in the control children, it was 2.14 ± 0.69 h. There seems to be no relationship between F elimination half-life and the serum albumin concentration in the NS patients. Also, no correlation was found between the amount of F (mg) excreted in urine during 2 or 6 h after administration (the time of complete absorption of F from the gastrointestinal tract, and the time of the drug diuretic effect, respectively) and the serum albumin concentration in the NS patients. Moreover, no significant difference in the cumulative F urinary excretion was found between both groups of children. The data indicate that factors in addition to serum albumin concentration play a role in the elimination kinetics of F in nephrotic children.
Speculation: In children with steroid-responsive nephrotic syndrome furosemide administered orally at a dose of 2 mg/kg of actual weight (plus edema), is absorbed from the gastrointestinal tract significantly more rapidly than in the control group of patients. After a 2-wk coarse of treatment with prednisone, the absorption rate of the drug is slowed down. It is suggested that this is caused by a larger extracellular compartment in an edematous nephrotic into which the furosemide may move.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prandota, J. Pharmacokinetics of Furosemide Urinary Elimination by Nephrotic Children. Pediatr Res 17, 141–147 (1983). https://doi.org/10.1203/00006450-198302000-00012
Issue Date:
DOI: https://doi.org/10.1203/00006450-198302000-00012
This article is cited by
-
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome
Pediatric Nephrology (2020)
-
Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy
Clinical and Experimental Nephrology (2015)
-
The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications
Pediatric Nephrology (2014)
-
Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications
Pediatric Nephrology (2007)
-
Diuretic effect and disposition of furosemide in cystic fibrosis
European Journal of Clinical Pharmacology (1991)